Combination therapies with mitogen-activated protein kinase kinase inhibitors and immune checkpoint inhibitors in non-small cell lung cancer

Combination therapies with mitogen-activated protein kinase kinase inhibitors and immune checkpoint inhibitors in non-small cell lung cancer

Bibliographic Details
Main Authors: Jia-Li Xu, Xin-Zhu Wang, Hu-Ning Jiang, Yi Chen, Rong Wang, Yong-Qian Shu, Pei-Fang Wei.
Format: Article
Language:English
Published: Wolters Kluwer 2020-10-01
Series:Chinese Medical Journal
Online Access:http://journals.lww.com/10.1097/CM9.0000000000001070
id doaj-b1de62f1c99f4bd985fef07d00191714
record_format Article
spelling doaj-b1de62f1c99f4bd985fef07d001917142020-12-02T08:02:09ZengWolters KluwerChinese Medical Journal0366-69992542-56412020-10-01133202495249710.1097/CM9.0000000000001070202010200-00015Combination therapies with mitogen-activated protein kinase kinase inhibitors and immune checkpoint inhibitors in non-small cell lung cancerJia-Li XuXin-Zhu WangHu-Ning JiangYi ChenRong WangYong-Qian ShuPei-Fang Wei.http://journals.lww.com/10.1097/CM9.0000000000001070
collection DOAJ
language English
format Article
sources DOAJ
author Jia-Li Xu
Xin-Zhu Wang
Hu-Ning Jiang
Yi Chen
Rong Wang
Yong-Qian Shu
Pei-Fang Wei.
spellingShingle Jia-Li Xu
Xin-Zhu Wang
Hu-Ning Jiang
Yi Chen
Rong Wang
Yong-Qian Shu
Pei-Fang Wei.
Combination therapies with mitogen-activated protein kinase kinase inhibitors and immune checkpoint inhibitors in non-small cell lung cancer
Chinese Medical Journal
author_facet Jia-Li Xu
Xin-Zhu Wang
Hu-Ning Jiang
Yi Chen
Rong Wang
Yong-Qian Shu
Pei-Fang Wei.
author_sort Jia-Li Xu
title Combination therapies with mitogen-activated protein kinase kinase inhibitors and immune checkpoint inhibitors in non-small cell lung cancer
title_short Combination therapies with mitogen-activated protein kinase kinase inhibitors and immune checkpoint inhibitors in non-small cell lung cancer
title_full Combination therapies with mitogen-activated protein kinase kinase inhibitors and immune checkpoint inhibitors in non-small cell lung cancer
title_fullStr Combination therapies with mitogen-activated protein kinase kinase inhibitors and immune checkpoint inhibitors in non-small cell lung cancer
title_full_unstemmed Combination therapies with mitogen-activated protein kinase kinase inhibitors and immune checkpoint inhibitors in non-small cell lung cancer
title_sort combination therapies with mitogen-activated protein kinase kinase inhibitors and immune checkpoint inhibitors in non-small cell lung cancer
publisher Wolters Kluwer
series Chinese Medical Journal
issn 0366-6999
2542-5641
publishDate 2020-10-01
url http://journals.lww.com/10.1097/CM9.0000000000001070
work_keys_str_mv AT jialixu combinationtherapieswithmitogenactivatedproteinkinasekinaseinhibitorsandimmunecheckpointinhibitorsinnonsmallcelllungcancer
AT xinzhuwang combinationtherapieswithmitogenactivatedproteinkinasekinaseinhibitorsandimmunecheckpointinhibitorsinnonsmallcelllungcancer
AT huningjiang combinationtherapieswithmitogenactivatedproteinkinasekinaseinhibitorsandimmunecheckpointinhibitorsinnonsmallcelllungcancer
AT yichen combinationtherapieswithmitogenactivatedproteinkinasekinaseinhibitorsandimmunecheckpointinhibitorsinnonsmallcelllungcancer
AT rongwang combinationtherapieswithmitogenactivatedproteinkinasekinaseinhibitorsandimmunecheckpointinhibitorsinnonsmallcelllungcancer
AT yongqianshu combinationtherapieswithmitogenactivatedproteinkinasekinaseinhibitorsandimmunecheckpointinhibitorsinnonsmallcelllungcancer
AT peifangwei combinationtherapieswithmitogenactivatedproteinkinasekinaseinhibitorsandimmunecheckpointinhibitorsinnonsmallcelllungcancer
_version_ 1724407809877999616

Similar Items